This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Bone marrow transplantation (BMT) can potentially cure sicklecelldisease, an inherited and painful blood disorder, but because of its potential drawbacks and costs, patients and caregivers often face the difficult decision of whether to undergo the procedure.
The incidence of stroke continues to increase for adults and children living with sicklecelldisease (SCD) despite the Stroke Prevention Trial in SickleCell Anemia (STOP) establishing standards of care like transfusions and tests to measure blood flow in the brain for those deemed high-risk, according to a new study.
The incidence of stroke continues to increase for adults and children living with sicklecelldisease (SCD), despite the Stroke Prevention Trial in SickleCell Anemia (STOP) establishing standards of care like transfusions and tests to measure blood flow in the brain for those deemed high-risk, according to a study published in Blood.
Stroke, Volume 55, Issue Suppl_1 , Page ATP147-ATP147, February 1, 2024. Background:White matter disease is a common phenomenon in patients with sicklecelldisease, that has been linked to cognitive impairment. However, there is no standardized approach for quantification of the cerebral disease burden.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP7-ATMP7, February 1, 2024. Background:Microvascular thromboinflammation is a major pathomechanism underlying vaso-occlusive crisis in patients with sicklecelldisease (SCD), yet its role underlying the elevated stroke risk in SCD is unclear.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP12-ATMP12, February 1, 2024. Background:Large-vessel vasculopathy (LVV), such as moyamoya syndrome, increases stroke risk with sicklecelldisease (SCD). Hemispheric OEF, as an indicator of increased stroke risk, may guide medical management and surgical intervention.
Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. In our cohort 7.2% of children with moyamoya had basilar artery stenosis.
Stroke, Volume 55, Issue Suppl_1 , Page AWP32-AWP32, February 1, 2024. Spinal cord infarction (SCI) poses a unique set of diagnostic and therapeutic challenges to clinicians. One patient was also found eligible and treated with IV-thrombolysis. We propose these findings as a basis for designing a larger scale study for result confirmation.
This ECG was recorded on a middle-aged male with sicklecelldisease and diffuse pain. found that such ECG findings only represented left main ACS in 14% of such ECGs: Only 23% of patients with the aVR STE pattern had any LM disease (fewer if defined as 50% stenosis). What do you think?
Stroke, Volume 55, Issue Suppl_1 , Page AWP218-AWP218, February 1, 2024. Introduction:Cerebral aneurysm frequency in sicklecelldisease (SCD) is higher than in the general population. Specific risk factors explaining this difference have not been previously explored.
Mauricio Del Rio The Adult Cardiac Anesthesiology Section of STS Adult Cardiac Surgery Database: 2020 Update on Quality and Outcomes The Annals of Thoracic Surgery September 2020 Victor Nauffal Short-Term Outcomes of Transcatheter Versus Isolated Surgical Aortic Valve Replacement for Mediastinal Radiation-Associated Severe Aortic Stenosis Circulation: (..)
Mark Erfe 2 Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves The Annals of Thoracic Surgery September 2020 Victor Nauffal 2 Short-Term Outcomes of Transcatheter Versus Isolated Surgical Aortic Valve Replacement for Mediastinal Radiation-Associated Severe Aortic Stenosis Circulation: Cardiovascular Interventions (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content